Dr. Partha Nandi takes a closer look at the varying medical viewpoints on whether all men should be screened for prostate cancer. He talks with a team of experts about screening and treatment options and life after prostate cancer surgery and radiation. Plus, prostate cancer survivors tell their stories of being diagnosed, treated and coping with the common side effects that have a negative impact on their lifestyles and intimate relationships.
Robert Ginyard is the Chief Dream Encouragement Officer of DiBi DiBi (Dream it. Believe it. Do it. Be it)- a lifestyle brand to encourage people to live out their dreams and not wait until a life threatening disease forces them to take action. Robert, a prostate cancer survivor, created DiBi DiBi after a restless night of tossing, turning, and self –examination about his life and the meaning of living a purposeful life. He is the producer and host of the podcast, Profiles of Dreamers and Doers; a show that highlights people who dared to dream and committed to make their dreams come true.
Robert has shared his story with ABC Online, The New York Times.com, The Wall Street Journal, and several other media outlets and publications. He has appeared before the United States Congress Senate Appropriations Committee to advocate for increasing funding for prostate cancer research to find a cure, and to help men who are living with the disease. Robert serves as the Chairman of the Board of Directors for ZERO: The End of Prostate Cancer. Learn more at dibidibination.com
Dr. Jeffrey Montgomery grew up in the suburbs of Detroit, went to the University of Michigan for his undergraduate education and graduated from the Columbia College of Physicians and Surgeons in 2001. He came back to Ann Arbor to complete his residency training at the U of M. During his research year, he began a two-year health service research fellowship under the direction of Dr. John Wei, and ultimately received his Masters of Health Administration at the University of Michigan School of Public Health as part of this program. He completed a urologic oncology fellowship at the University of Texas MD Anderson Cancer Center in 2008.
Dr. Montgomery focuses on the diagnosis and treatment of urologic cancers, with a special interest in the application of minimally-invasive surgical techniques for the treatment of these diseases. Some of his unique practice interests include robotic cystectomy with intracorporeal urinary diversions, MRI/US fusion prostate biopsy, and robotic inguinal lymph node dissection as a staging procedure for penile cancer. He also leads a prostate cancer focal therapy program. He practices both at the University of Michigan and the VA Hospital in Ann Arbor. His research activities include surgical technique, quality and outcomes assessment, evaluation of patient quality of life after surgical therapies, and medical economics and costs assessment as related to urologic cancers.
Dr. Salami is a fellowship-trained Urologic Oncologist and Assistant Professor of Urology at the University of Michigan. He obtained his MD from the College of Medicine, University of Ibadan, Nigeria. Thereafter, he graduated from the Master of Public Health program at Harvard University. He subsequently pursued his general surgical internship training at Brigham and Women’s Hospital in Boston, urology residency at Hofstra Northwell Health School of Medicine in New York, and urologic oncology fellowship at the University of Michigan in Ann Arbor.
Dr. Salami’s research interests are in early detection and staging of prostate and kidney cancer. He seeks to leverage novel imaging, machine learning, and next generation sequencing approaches to characterize cancer heterogeneity and tumor multifocality. The goal of his research is to develop novel cancer biomarkers and elucidate optimal paradigms for early detection of cancer, risk stratification, prognostication and prediction of treatment response.